powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1013335355
Iheanacho Emeruwa
MD, MBA
Pulmonary Disease
Los Angeles,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (1)
CCN 050262
Hospital
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
125
Unique beneficiaries
—
Total services
198
Distinct HCPCS
7
Medicare payment
$24K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 901 Pulmonary Disease providers in CA — bottom quintile (cohort median 927).
QUALITY · MIPS · 2024
Final MIPS score
87.5
Quality
79.4
Cost
73.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.53%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
36
Beneficiaries
—
Total drug cost
$10K
Distinct drugs
3
Brand share
100.0%
Top prescribed drugs
Tiotropium Br/Olodaterol Hcl
13 claims
Albuterol Sulfate
12 claims
Umeclidinium Bromide
11 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$401
Payment records
4
By payment type
Food and Beverage
$401
